North America
The North American Churg-Strauss syndrome market is primarily driven by advanced healthcare infrastructure and high levels of investment in medical research. The United States and Canada exhibit a growing awareness of rare autoimmune diseases, leading to increased diagnoses and improved treatment options. Ongoing research initiatives and clinical trials are crucial in developing...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian